pta20260902015 Unternehmensmitteilung für den Kapitalmarkt OncoRedox: Kapitalerhöhung in Höhe von EUR 219.244,00 vollständig gezeichnet Heidelberg (pta015/02.09.2026/12:35 UTC+2) Heidelberg, 2. September 2026 – Die OncoRedox gibt bekannt, dass im Rahmen der Bezugsrechtskapitalerhöhung mit folgender Privatplatzierung, welche heute beendet wurde, insgesamt 219.244 neue Aktien zum Bezugspreis von 1,00 EUR je Aktie gezeichnet wurden und somit […]
Category: Press Releases
02. September 2026
OncoRedox: Capital increase in the amount of EUR 219,244.00 fully subscribed
30. April 2024
OncoRedox: Executive Board member Jens Ravens leaves the Company on April 30, 2024
EQS-News: OncoRedox / Key word(s): Personnel OncoRedox: Executive Board member Jens Ravens leaves the Company on April 30, 2024 30.04.2024 / 15:00 CET/CESTThe issuer is solely responsible for the content of this announcement. OncoRedox: Executive Board member Jens Ravens leaves the Company on April 30, 2024 Berlin (Germany), April 30, 2024 – Jens Ravens, Executive […]
14. March 2024
OncoRedox publishes financial results for fiscal year 2023
EQS-News: OncoRedox / Key word(s): Annual Results/Annual ReportOncoRedox publishes financial results for fiscal year 2023 14.03.2024 / 08:00 CET/CESTThe issuer is solely responsible for the content of this announcement. OncoRedox publishes financial results for fiscal year 2023 Berlin (Germany), March 14, 2024 – OncoRedox (FSE: ECX, the “Company”) today reported financial […]
15. February 2024
OncoRedox: Jochen Hummel appointed to the Supervisory Board to replace Heikki Lanckriet
EQS-News: OncoRedox / Key word(s): Personnel OncoRedox: Jochen Hummel appointed to the Supervisory Board to replace Heikki Lanckriet 15.02.2024 / 10:00 CET/CESTThe issuer is solely responsible for the content of this announcement. OncoRedox: Jochen Hummel appointed to the Supervisory Board to replace Heikki Lanckriet Berlin, February 15, 2024 – OncoRedox (Frankfurt General […]
31. January 2024
OncoRedox: Supervisory Board of OncoRedox appoints Hansjörg Plaggemars as member of the Executive Board
EQS-News: OncoRedox / Key word(s): Personnel OncoRedox: Supervisory Board of OncoRedox appoints Hansjörg Plaggemars as member of the Executive Board 31.01.2024 / 15:30 CET/CESTThe issuer is solely responsible for the content of this announcement. OncoRedox: Supervisory Board of OncoRedox appoints Hansjörg Plaggemars as member of the Executive Board Berlin, January 31, […]
26. January 2024
OncoRedox: Resignation of Supervisory Board Member Dr Heikki Lanckriet (PhD)
EQS-News: OncoRedox / Key word(s): Personnel OncoRedox: Resignation of Supervisory Board Member Dr Heikki Lanckriet (PhD) 26.01.2024 / 13:16 CET/CESTThe issuer is solely responsible for the content of this announcement. OncoRedox: Resignation of Supervisory Board Member Dr Heikki Lanckriet (PhD) Berlin, Germany, January 26, 2024 – Dr Heikki Lanckriet (PhD) has informed the competent bodies of OncoRedox […]